CG Oncology, Inc. Common stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $55,653,000.
Profit Margin
| 2023 | 204K | -48.60M | -23826.96% |
|---|
CGON Income Statement (2023 – 2023)
| 2023 | |
|---|---|
Revenue | |
Revenue | 204K |
Cost of revenue | 0 |
Gross profit | 204K |
Operating exp. | |
Research and development | 45.75M |
Selling and marketing | 0 |
Total operating expenses | 55.65M |
Operating income | -55.44M |
Other income (expenses), net | 6.84M |
Income before tax | -48.60M |
Income tax expense | 0 |
Net income | -48.60M |
Earnings per share | |
Basic EPS | -15.65 |
Diluted EPS | -15.65 |
| Data source |